Seoulin Bioscience Co.Ltd (038070) — Financial Flexibility Index
Seoulin Bioscience Co.Ltd (038070) has a Financial Flexibility Index of 0.02x as of December 2025. Free cash flow of ₩642.66 Million (operating CF ₩631.76 Million minus capex ₩10.90 Million) represents 0% of total liabilities (₩32.75 Billion). Check Seoulin Bioscience Co.Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Seoulin Bioscience Co.Ltd Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Seoulin Bioscience Co.Ltd across 13 annual periods. See Seoulin Bioscience Co.Ltd (038070) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Seoulin Bioscience Co.Ltd (2013–2025)
Year-by-year free cash flow to debt coverage for Seoulin Bioscience Co.Ltd. For the full company profile including market capitalisation, see market cap of Seoulin Bioscience Co.Ltd.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.16x | ₩5.27 Billion | ₩4.76 Billion | ₩32.75 Billion | ▲ +162.3% |
| 2024 | -0.26x | ₩-4.55 Billion | ₩-4.61 Billion | ₩17.63 Billion | ▼ -520.4% |
| 2023 | 0.06x | ₩1.90 Billion | ₩930.57 Million | ₩31.04 Billion | ▲ +185.9% |
| 2022 | -0.07x | ₩-3.65 Billion | ₩-4.36 Billion | ₩51.08 Billion | ▼ -141.6% |
| 2021 | 0.17x | ₩10.59 Billion | ₩8.92 Billion | ₩61.71 Billion | ▼ -23.0% |
| 2020 | 0.22x | ₩4.09 Billion | ₩3.68 Billion | ₩18.33 Billion | ▼ -38.3% |
| 2019 | 0.36x | ₩7.59 Billion | ₩7.32 Billion | ₩21.00 Billion | ▲ +37.2% |
| 2018 | 0.26x | ₩4.58 Billion | ₩4.17 Billion | ₩17.39 Billion | ▼ -48.7% |
| 2017 | 0.51x | ₩10.03 Billion | ₩1.30 Billion | ₩19.54 Billion | ▼ -8.1% |
| 2016 | 0.56x | ₩9.97 Billion | ₩2.76 Billion | ₩17.87 Billion | ▲ +47.7% |
| 2015 | 0.38x | ₩7.86 Billion | ₩4.12 Billion | ₩20.80 Billion | ▲ +89.7% |
| 2014 | 0.20x | ₩3.50 Billion | ₩2.74 Billion | ₩17.57 Billion | ▼ -24.9% |
| 2013 | 0.27x | ₩4.99 Billion | ₩4.94 Billion | ₩18.82 Billion | — |